Skip to content

Synthesis and Computational Evaluation of Substituted Analogues of 4-Sulfonamide Phenylhydrazones as Potential Anticancer Agents: Molecular Docking, Physicochemical Properties, ADME-Tox, and DFT Analysis.

Sep 2026 · Current Organic Synthesis · 0 citations
Medicine

TL;DR

Promising compounds like SBB-2, SBB-3, SBB-5, SBB-6, and SBB-7 exhibit favourable physicochemical properties, high drug-likeness, solubility, and a non-toxic profile, making them strong candidates for further development of a promising drug.

Abstract

INTRODUCTION Ten derivatives of benzenesulfonamide (SBB-1 to 10) have been synthesized via the condensation of terminal ketone and aldehyde with aromatic 4-sulfonamide phenylhydrazine.

Methods

1H NMR, 13C NMR, IR, UV, and GC-MS were used to confirm the synthesized derivatives. The in vitro cytotoxicity of the synthesized sulfonamide derivatives SBB (1-10) was evaluated against the A549 human lung cancer cell line, using doxorubicin as the reference standard.

Results

The compound SBB-5 (IC50 16.36 ± 0.41 μM) demonstrated high anticancer potency due to the presence of a hydroxy group on the phenyl ring against all tested strains.

Discussion

The binding conformation of the most potent benzenesulfonamide (SBB-5) with the EGFR kinase (PDB code: 1M17) was ascertained by molecular docking studies. According to ADMET and DFT studies, the synthesized compounds showed favorable properties.

Conclusion

Promising compounds like SBB-2, SBB-3, SBB-5, SBB-6, and SBB-7 exhibit favourable physicochemical properties, high drug-likeness, solubility, and a non-toxic profile, making them strong candidates for further development of a promising drug.

View source

Similar papers

Open access Sep 2026

Design, Synthesis, and Integrated In Silico and In Vitro Evaluation of Chloro-Substituted Salicylaldehyde Benzoylhydrazones as Anticancer Agents

Background: Building on earlier work with methoxy-, dimethoxy-, bromo-, and nitro-substituted salicylaldehyde benzoylhydrazones, we synthesized and evaluated new 4-chloro- and 5-chloro derivatives bearing an additional chlorine substituent on the hydrazide-derived phenyl ring to further explore the impact of halogenati...

B. Nikolova-Mladenova, R. Mihaylova, Stilyana Kostova et al. · 0 citations
Open access Sep 2026

Synthesis, Cytotoxic Evaluation, Molecular Docking, and In Silico ADME Studies of Novel Quinazolinone-Based Aldazine Derivatives Using Chitosan Sulfonic Acid as a Recyclable Catalyst

A series of novel quinazolinone-based aldazine and ketazine derivatives (4a–l and 6) was synthesized through the condensation of hydrazine intermediate 2 with substituted aldehydes and isatin using chitosan sulfonic acid (CS–SO3H) as a recyclable heterogeneous catalyst. The reactions were performed under conventional r...

Tariq Z. Abolibda, Yousef R. Alsuhaymi, B. Farag et al. · 0 citations
Sep 2026

Synthesis, characterization and molecular docking studies of novel 6-Imino-2-Methyl-4-substituted- 6H -1,3-Thiazine-5-Carbonitrile derivatives as potential antibacterial agents

Favourable binding energies and significant intermolecular interactions highlight these thiazine derivatives as promising leads for further antibacterial development.

Suhas Salunkhe, S. D. Patil, P. J. Menezes et al. · 0 citations
Open access Sep 2026

Synthesis, Characterization, Molecular Docking and Study biological Activity of some New Heterocyclic Derivatives from a Sulfa Drug

The results indicate that structural modification of sulfadiazine through heterocyclic ring formation significantly enhances antibacterial activity and binding affinity, suggesting their potential as promising antimicrobial agents.

Rusul Zamil Abdulhassan, N. Majeed · 0 citations
Open access Sep 2026

Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives

Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.

Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.